Hypolipoproteinemia: Difference between revisions
No edit summary |
(→Causes) |
||
(50 intermediate revisions by 4 users not shown) | |||
Line 2: | Line 2: | ||
{{Hypolipoproteinemia}} | {{Hypolipoproteinemia}} | ||
{{CMG}}; {{AE}} {{MM}}; {{AKI}}; {{TarekNafee}} | {{CMG}}; {{AE}} {{MM}}; {{AKI}}; {{TarekNafee}} | ||
{{SK}} Hypolipidemia, low lipoprotein | |||
==Overview== | |||
Hypolipoproteinemia (also known as ''hypolipidemia or low lipoproteins'') is defined as presence of low levels of one or more type of [[lipoproteins]]. Hypolipoproteinemia may present as primary genetic disorders or as a secondary complication of underlying medical conditions. After ruling out common secondary causes of hypolipoproteinemia, the clinician must begin the work-up for primary causes. | |||
Patients with hypoproteinemia may present with low [[LDL Cholesterol|LDL]], or low [[HDL]]. Patients with low LDL commonly present with [[diarrhea]], [[vomiting]], or [[failure to thrive]] (in infanthood). Patients with primary low HDL are usually asymptomatic however, patients diagnosed with low HDL due to [[Tangier's disease]], [[ApoA1|ApoA1 deficiency]], or [[LCAT deficiency]] have specific clinical findings such as [[Cornea|corneal]] opacities, [[xanthomas]], and renal failure. Work up for primary hypolipoproteinemias begins with careful examination of the [[lipid panel]] and may involve screening of family members. Confirmatory [[gene sequencing]] is the gold standard diagnostic test for all hypolipoproteinemias. | |||
==Causes== | |||
The following are the list of conditions which can cause low LDL C and low HDL C levels: | |||
Primary lipoprotein abnormalities | |||
* [[Hypoalphalipoproteinemia]] (Apolipoprotein A-1 deficiency). Low HDL | |||
* [[Hypobetalipoproteinemia]] and [[Abetalipoproteinemia]]. Low LDL and VLDL, but not low HDL | |||
* [[Chylomicron retention disease]] | |||
* Cholesteryl ester transfer protein (CETP) elevation | |||
* Familial combined hypolipidemia (does not increase risk of atherosclerosis) | |||
* [[LCAT]] deficiency | |||
* Proprotein convertase subtilisin/kexin type 9 (PCSK9) loss of function or deficiency | |||
* Adenosine triphosphate (ATP)-binding cassette transporter (ABCA1) gene mutations | |||
** Familial HDL deficiency. ''This is the most common cause of low HDL and coronary artery disease.'' | |||
** [[Tangier disease]] | |||
Secondary causes | |||
*[[Anemia]] | |||
*[[Chronic inflammation]] | |||
*[[Chronic liver disease]] | |||
*Critical illness | |||
*[[Hyperthyroidism]] | |||
*[[Infection]] | |||
*[[Malabsorption]] | |||
*[[Malignancy]] | |||
==Classification== | ==Classification== | ||
Based on the etiology hypolipoproteinemias are classified into primary and secondary hypolipoproteinemias. The following algorithm is a list of various etiologies under primary and secondary hypolipoproteinemias: | |||
{{familytree/start |summary=Hypolipoproteinemia}} | {{familytree/start |summary=Hypolipoproteinemia}} | ||
{{familytree | | | | | | | A01 | | | | | | | | A01= '''Hypolipoproteinemia'''}} | {{familytree | | | | | | | A01 | | | | | | | | A01= '''Hypolipoproteinemia'''}} | ||
Line 17: | Line 39: | ||
{{familytree | B01 | | | | | | | | | | | | | | B02 | B01= '''Primary'''<br>(Genetic)| B02= '''Secondary'''}} | {{familytree | B01 | | | | | | | | | | | | | | B02 | B01= '''Primary'''<br>(Genetic)| B02= '''Secondary'''}} | ||
{{familytree | |!| | | | | | | | | | | | | | | |!| }} | {{familytree | |!| | | | | | | | | | | | | | | |!| }} | ||
{{familytree | C01 | | | | | | | | | | | | | | C02 | C01=[[Abetalipoproteinemia]]<br> Apolipoprotein 1 deficiency <br> [[Chylomicron retention disease]] <br> Familial combined hypolipidemia <br> [[Hypobetalipoproteinemia]]<br> [[LCAT]] deficiency<br> Primary alphalipoproteinemia <br> | {{familytree | C01 | | | | | | | | | | | | | | C02 | C01=[[Abetalipoproteinemia]]<br> Apolipoprotein 1 deficiency <br> [[Chylomicron retention disease]] <br> Familial combined hypolipidemia <br> [[Hypobetalipoproteinemia]]<br> [[LCAT]] deficiency<br>Primary alphalipoproteinemia <br> PCSK9 deficiency <br> [[Tangier disease]]| C02= [[Anemia]] <br> Critical illness<br> [[Chronic inflammation]] <br> [[Chronic liver disease]] <br> [[Hyperthyroidism]] <br>[[Infection]] <br> [[Malabsorption]] <br>[[Malignancy]]}} | ||
{{familytree/end}} | {{familytree/end}} | ||
==Differential Diagnosis== | |||
== | <small>The table below provides a brief synopsis of the lipid profile findings in several of the most common primary hypolipidemic disorders affecting the LDL C levels: | ||
{| class="wikitable" | {| class="wikitable" | ||
! | ! | ||
Line 123: | Line 113: | ||
|} | |} | ||
The table below is a differential diagnosis for low HDL C disorders: | |||
{| class="wikitable" | |||
! | |||
!Familial LCAT | |||
Deficiency | |||
!Fish Eye | |||
Disease | |||
!Homozygous Tangier | |||
Disease | |||
!Heterozygous Tangier | |||
Disease | |||
!Apo A1 Deficiency | |||
|- | |||
|Gene Defect | |||
|LCAT | |||
|LCAT | |||
|ABCA1 | |||
|ABCA1 | |||
|Apo A1 | |||
|- | |||
|Inheritance | |||
|Autosomal Recessive | |||
|Autosomal Recessive | |||
|Autosomal Recessive | |||
|Autosomal Recessive | |||
|Autosomal Dominant | |||
|- | |||
|Pathogenesis | |||
| | |||
*Loss of alpha and beta LCAT function | |||
*Failure of cholesterol ester formation. | |||
|Loss of alpha function only | |||
| | |||
Pre beta-1 HDL fails to picks up free cholesterol from cells due to mutation in ABCA1 transporter. | |||
|Similar to homozygous | |||
|Defective synthesis of Apo A1 resulting in failure of maturation of HDL and defective reverse cholesterol transport. | |||
|- | |||
|Clinical Features | |||
| | |||
*Annular corneal opacity | |||
*Anaemia | |||
*Progressive renal disease with proteinuria | |||
| | |||
*Corneal opacities only | |||
*Normal renal function | |||
| | |||
*Large yellow-orange tonsils | |||
*Dense central corneal opacity | |||
*Relapsing and remitting course of neuropathy | |||
|Asymptomatic | |||
| | |||
*Corneal Opacities | |||
*Tuboeruptive, Planar and palmar Xanthomas | |||
*Premature Heart Disease | |||
|- | |||
|Lipid Panel | |||
| | |||
*Elevated Free cholesterol | |||
*HDL-C < 10 mg/dL | |||
*Low Apo A1 and Apo AII | |||
*Elevated Apo E and Triglycerides | |||
*Low LDL C | |||
| | |||
*Elevated free cholesterol | |||
*HDL C < 27 mg/dL | |||
*Apo A1<30mg/dl and low Apo A2 | |||
*Elevated Apo E and Triglycerides | |||
*Normal LDL and VLDL | |||
| | |||
*HDL < 5% of normal | |||
*Apo A1 < 1% of normal | |||
=== | *LDL < 40% of normal | ||
| | |||
*HDL C, Apo A1 and LDL 50% less than normal. | |||
| | |||
*Undetectable Apo A1 | |||
*HDL C less than 10mg/dl | |||
*Normal or low Apo AII | |||
*LDL C normal | |||
*Triglyceride normal or elevated | |||
|- | |||
|2D Gel Electrophoresis | |||
|Pre β-1 and α-4 HDL, LDL with β mobility due to Lipoprotien-X | |||
|Pre β-1and α-4 HDL with normal pre-β LDL. | |||
|Only preβ-1 HDL present | |||
| | |||
*Lack of large α-1 and α-2 HDL particles | |||
*Normal preβ-1 HDL | |||
|Lack of Apo A1 containing HDL particles. | |||
|} | |||
</small> | |||
<small> | |||
'''Approch algorithm to a patient with low HDL C:'''<ref name="pmid23043194">{{cite journal| author=Rader DJ, deGoma EM| title=Approach to the patient with extremely low HDL-cholesterol. | journal=J Clin Endocrinol Metab | year= 2012 | volume= 97 | issue= 10 | pages= 3399-407 | pmid=23043194 | doi=10.1210/jc.2012-2185 | pmc=3462950 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23043194 }} </ref> | |||
{{Family tree/start}} | |||
{{Family tree | | | | | | A01 | | | |A01= HDL <20mg/dl in the absence of severe hypertriglyceridemia}} | |||
{{Family tree | | | | | | |!| | | | | }} | |||
{{Family tree | | | | | | |!| | | | | }} | |||
{{Family tree | | | | | | C01 | | | |C01= Rule out secondary causes of low HDL C<br>Paraproteinemia from multiple myeloma<br>Anabolic steriod use<br>Fibrate use<br>Thiazolidinedione use}} | |||
{{Family tree | | | | | | |!| | | | | }} | |||
{{Family tree | | | | | | |!| | | | | }} | |||
{{Family tree | | | | | | E01 | | | |E01= Consider Monogenic primary disorders<br>Order ApoA1}} | |||
{{Family tree | | | | | | |!| | | | | }} | |||
{{Family tree | | |,|-|-|-|^|-|-|.|}} | |||
{{Family tree | |F01| | | | |F02| |F01= >5mg/dl| F02= Undetectable or <5mg/dl}} | |||
{{Family tree | | |!| | | | | | |!| | | | | | }} | |||
{{Family tree | |G01| | | | |G02| | | |G01=Familial LCAT deficiency <br>High plasma FC:CE ratio<br>2D electrophoresis: Prebeta and Alpha-4, Beta mobility of LDL|G02= Do 2D Gel Electrophoresis with Apo A1 Immunoassay}} | |||
{{Family tree | | | | | | | | | |!| | | | }} | |||
{{Family tree | | | | | | | |,|-|^|-|-|.| }} | |||
{{Family tree | | | | | | | H01| | |H02|H01= Complete absence of Apo A1 containing HDL C|H02= Only Pre-Beta HDL C}} | |||
{{Family tree | | | | | | | |!| | | | |!| }} | |||
{{Family tree | | | | | | |I01| | |I02|I01=Apo A1 Deficiency<br><SMALL>(Confirm with gene sequencing)</SMALL>|I02=Homozygous Tangier Disease<br><SMALL>(Confirm with gene sequencing)</SMALL>}} | |||
{{Family tree/end}} | |||
'''Approach algorithm to a patient with low low LDL C:''' | |||
{{Family tree/start}} | |||
{{Family tree | | | | | | A01 | | | |A01= Low LDL C <5th percentile}} | |||
{{Family tree | | | | | | |!| | | | | }} | |||
{{Family tree | | | | | | |!| | | | | }} | |||
{{Family tree | | | | | | C01 | | | |C01= Rule out secondary causes of low LDL}} | |||
{{Family tree | | | | | | |!| | | | | }} | |||
{{Family tree | | | | | | |!| | | | | }} | |||
{{Family tree | | | | | | E01 | | | |E01= Lipid panel}} | |||
{{Family tree | | | | | | |!| | | | | }} | |||
{{Family tree | | |,|-|-|-|^|-|-|.|}} | |||
{{Family tree | |F01| | | | |F02| |F01= Normal Triglycerides| F02=Low Triglycerides}} | |||
{{Family tree | | |!| | | | | | |!| | | | | | }} | |||
{{Family tree | |G01| | | | |G02| | | |G01=Chlyomicron retention disease<br><SMALL>(Confirm with gene sequencing)</SMALL>|G02=Screen the lipid panel of the patient's parents}} | |||
{{Family tree | | | | | | | | | |!| | | | }} | |||
{{Family tree | | | | | | | |,|-|^|-|-|.| }} | |||
{{Family tree | | | | | | | H01| | |H02|H01=Normal Parental Lipid Panel|H02=If Parental Lipid Panel <50% of Normal on:<br>*LDL<br>*Total Cholesterol<br>*Triglycerides}} | |||
{{Family tree | | | | | | | |!| | | | |!| }} | |||
{{Family tree | | | | | | |I01| | |I02|I01=Abetalipoproteinemia<br><SMALL>(Confirm with gene sequencing)</SMALL>|I02=Familial homozygous hypobetalipoproteinemia<br><SMALL>(Confirm with gene sequencing)</SMALL>}} | |||
{{Family tree/end}} | |||
</small> | |||
==References== | ==References== |
Latest revision as of 14:05, 2 October 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]; Aravind Kuchkuntla, M.B.B.S[3]; Tarek Nafee, M.D. [4] Synonyms and keywords: Hypolipidemia, low lipoprotein
Overview
Hypolipoproteinemia (also known as hypolipidemia or low lipoproteins) is defined as presence of low levels of one or more type of lipoproteins. Hypolipoproteinemia may present as primary genetic disorders or as a secondary complication of underlying medical conditions. After ruling out common secondary causes of hypolipoproteinemia, the clinician must begin the work-up for primary causes. Patients with hypoproteinemia may present with low LDL, or low HDL. Patients with low LDL commonly present with diarrhea, vomiting, or failure to thrive (in infanthood). Patients with primary low HDL are usually asymptomatic however, patients diagnosed with low HDL due to Tangier's disease, ApoA1 deficiency, or LCAT deficiency have specific clinical findings such as corneal opacities, xanthomas, and renal failure. Work up for primary hypolipoproteinemias begins with careful examination of the lipid panel and may involve screening of family members. Confirmatory gene sequencing is the gold standard diagnostic test for all hypolipoproteinemias.
Causes
The following are the list of conditions which can cause low LDL C and low HDL C levels:
Primary lipoprotein abnormalities
- Hypoalphalipoproteinemia (Apolipoprotein A-1 deficiency). Low HDL
- Hypobetalipoproteinemia and Abetalipoproteinemia. Low LDL and VLDL, but not low HDL
- Chylomicron retention disease
- Cholesteryl ester transfer protein (CETP) elevation
- Familial combined hypolipidemia (does not increase risk of atherosclerosis)
- LCAT deficiency
- Proprotein convertase subtilisin/kexin type 9 (PCSK9) loss of function or deficiency
- Adenosine triphosphate (ATP)-binding cassette transporter (ABCA1) gene mutations
- Familial HDL deficiency. This is the most common cause of low HDL and coronary artery disease.
- Tangier disease
Secondary causes
- Anemia
- Chronic inflammation
- Chronic liver disease
- Critical illness
- Hyperthyroidism
- Infection
- Malabsorption
- Malignancy
Classification
Based on the etiology hypolipoproteinemias are classified into primary and secondary hypolipoproteinemias. The following algorithm is a list of various etiologies under primary and secondary hypolipoproteinemias:
Hypolipoproteinemia | |||||||||||||||||||||||||||||||||||||||||
Primary (Genetic) | Secondary | ||||||||||||||||||||||||||||||||||||||||
Abetalipoproteinemia Apolipoprotein 1 deficiency Chylomicron retention disease Familial combined hypolipidemia Hypobetalipoproteinemia LCAT deficiency Primary alphalipoproteinemia PCSK9 deficiency Tangier disease | Anemia Critical illness Chronic inflammation Chronic liver disease Hyperthyroidism Infection Malabsorption Malignancy | ||||||||||||||||||||||||||||||||||||||||
Differential Diagnosis
The table below provides a brief synopsis of the lipid profile findings in several of the most common primary hypolipidemic disorders affecting the LDL C levels:
Abetalipoprotienemia | Familial Homozygous
Hypobetalipoproteinemia |
Familial Heterozygous
Hypobetalipoproteinemia |
PCSK9 deficiency | Chylomicron Retention
Disease |
Familial Combined
Hypolipidemia | |
---|---|---|---|---|---|---|
LDL C | ↓↓↓ (0) | ↓↓↓ | ↓ | ↓ | ↓↓ | ↓↓ |
Apo B | ↓↓↓( 0) | ↓↓↓ | ↓ | N | ↓↓ | N |
TG | ↓↓↓ | ↓↓↓ | ↓ | ↓ | N | ↓ |
TC | ↓↓↓ | ↓↓↓ | ↓ | ↓ | ↓↓ | ↓ |
HDL | ↓↓ | ↓↓ | N | N | ↓↓ | ↓↓ |
VLDL | ↓↓ | ↓↓ | ↓ | N | ↓↓ | ↓ |
Apo A1 | ↓↓ | ↓↓ | ↓ | N | ↓↓ | N |
The table below is a differential diagnosis for low HDL C disorders:
Familial LCAT
Deficiency |
Fish Eye
Disease |
Homozygous Tangier
Disease |
Heterozygous Tangier
Disease |
Apo A1 Deficiency | |
---|---|---|---|---|---|
Gene Defect | LCAT | LCAT | ABCA1 | ABCA1 | Apo A1 |
Inheritance | Autosomal Recessive | Autosomal Recessive | Autosomal Recessive | Autosomal Recessive | Autosomal Dominant |
Pathogenesis |
|
Loss of alpha function only |
Pre beta-1 HDL fails to picks up free cholesterol from cells due to mutation in ABCA1 transporter. |
Similar to homozygous | Defective synthesis of Apo A1 resulting in failure of maturation of HDL and defective reverse cholesterol transport. |
Clinical Features |
|
|
|
Asymptomatic |
|
Lipid Panel |
|
|
|
|
|
2D Gel Electrophoresis | Pre β-1 and α-4 HDL, LDL with β mobility due to Lipoprotien-X | Pre β-1and α-4 HDL with normal pre-β LDL. | Only preβ-1 HDL present |
|
Lack of Apo A1 containing HDL particles. |
Approch algorithm to a patient with low HDL C:[1]
HDL <20mg/dl in the absence of severe hypertriglyceridemia | |||||||||||||||||||||||||||||||
Rule out secondary causes of low HDL C Paraproteinemia from multiple myeloma Anabolic steriod use Fibrate use Thiazolidinedione use | |||||||||||||||||||||||||||||||
Consider Monogenic primary disorders Order ApoA1 | |||||||||||||||||||||||||||||||
>5mg/dl | Undetectable or <5mg/dl | ||||||||||||||||||||||||||||||
Familial LCAT deficiency High plasma FC:CE ratio 2D electrophoresis: Prebeta and Alpha-4, Beta mobility of LDL | Do 2D Gel Electrophoresis with Apo A1 Immunoassay | ||||||||||||||||||||||||||||||
Complete absence of Apo A1 containing HDL C | Only Pre-Beta HDL C | ||||||||||||||||||||||||||||||
Apo A1 Deficiency (Confirm with gene sequencing) | Homozygous Tangier Disease (Confirm with gene sequencing) | ||||||||||||||||||||||||||||||
Approach algorithm to a patient with low low LDL C:
Low LDL C <5th percentile | |||||||||||||||||||||||||||||||
Rule out secondary causes of low LDL | |||||||||||||||||||||||||||||||
Lipid panel | |||||||||||||||||||||||||||||||
Normal Triglycerides | Low Triglycerides | ||||||||||||||||||||||||||||||
Chlyomicron retention disease (Confirm with gene sequencing) | Screen the lipid panel of the patient's parents | ||||||||||||||||||||||||||||||
Normal Parental Lipid Panel | If Parental Lipid Panel <50% of Normal on: *LDL *Total Cholesterol *Triglycerides | ||||||||||||||||||||||||||||||
Abetalipoproteinemia (Confirm with gene sequencing) | Familial homozygous hypobetalipoproteinemia (Confirm with gene sequencing) | ||||||||||||||||||||||||||||||
References
- ↑ Rader DJ, deGoma EM (2012). "Approach to the patient with extremely low HDL-cholesterol". J Clin Endocrinol Metab. 97 (10): 3399–407. doi:10.1210/jc.2012-2185. PMC 3462950. PMID 23043194.